UniProt ID | SCML2_HUMAN | |
---|---|---|
UniProt AC | Q9UQR0 | |
Protein Name | Sex comb on midleg-like protein 2 | |
Gene Name | SCML2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 700 | |
Subcellular Localization | Nucleus . | |
Protein Description | Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development (By similarity).. | |
Protein Sequence | MGQTVNEDSMDVKKENQEKTPQSSTSSVQRDDFHWEEYLKETGSISAPSECFRQSQIPPVNDFKVGMKLEARDPRNATSVCIATVIGITGARLRLRLDGSDNRNDFWRLVDSPDIQPVGTCEKEGDLLQPPLGYQMNTSSWPMFLLKTLNGSEMASATLFKKEPPKPPLNNFKVGMKLEAIDKKNPYLICPATIGDVKGDEVHITFDGWSGAFDYWCKYDSRDIFPAGWCRLTGDVLQPPGTSVPIVKNIAKTESSPSEASQHSMQSPQKTTLILPTQQVRRSSRIKPPGPTAVPKRSSSVKNITPRKKGPNSGKKEKPLPVICSTSAASLKSLTRDRGMLYKDVASGPCKIVMSTVCVYVNKHGNFGPHLDPKRIQQLPDHFGPGPVNVVLRRIVQACVDCALETKTVFGYLKPDNRGGEVITASFDGETHSIQLPPVNSASFALRFLENFCHSLQCDNLLSSQPFSSSRGHTHSSAEHDKNQSAKEDVTERQSTKRSPQQTVPYVVPLSPKLPKTKEYASEGEPLFAGGSAIPKEENLSEDSKSSSLNSGNYLNPACRNPMYIHTSVSQDFSRSVPGTTSSPLVGDISPKSSPHEVKFQMQRKSEAPSYIAVPDPSVLKQGFSKDPSTWSVDEVIQFMKHTDPQISGPLADLFRQHEIDGKALFLLKSDVMMKYMGLKLGPALKLCYYIEKLKEGKYS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | GQTVNEDSMDVKKEN CCCCCCCCCCCHHHH | 15.65 | 21815630 | |
10 | Sulfoxidation | QTVNEDSMDVKKENQ CCCCCCCCCCHHHHH | 12.12 | 21406390 | |
13 | Sumoylation | NEDSMDVKKENQEKT CCCCCCCHHHHHCCC | 50.54 | - | |
13 | Sumoylation | NEDSMDVKKENQEKT CCCCCCCHHHHHCCC | 50.54 | - | |
13 | Ubiquitination | NEDSMDVKKENQEKT CCCCCCCHHHHHCCC | 50.54 | 32015554 | |
19 | Ubiquitination | VKKENQEKTPQSSTS CHHHHHCCCCCCCCC | 56.60 | 29967540 | |
20 | Phosphorylation | KKENQEKTPQSSTSS HHHHHCCCCCCCCCC | 26.30 | 21815630 | |
23 | Phosphorylation | NQEKTPQSSTSSVQR HHCCCCCCCCCCHHH | 36.47 | 29449344 | |
32 | Ubiquitination | TSSVQRDDFHWEEYL CCCHHHCCCCHHHHH | 39.23 | 24816145 | |
40 | Ubiquitination | FHWEEYLKETGSISA CCHHHHHHHHCCCCC | 52.94 | 29967540 | |
64 | Ubiquitination | IPPVNDFKVGMKLEA CCCCCCCCCCEEEEE | 40.52 | 29967540 | |
68 | Ubiquitination | NDFKVGMKLEARDPR CCCCCCEEEEECCCC | 36.93 | - | |
123 | Methylation | QPVGTCEKEGDLLQP CCCCCCCCCCCCCCC | 69.97 | 23583077 | |
148 | Phosphorylation | WPMFLLKTLNGSEMA CCEEEEHHCCCCCCC | 25.98 | 22210691 | |
152 | Phosphorylation | LLKTLNGSEMASATL EEHHCCCCCCCCCCC | 24.11 | 22210691 | |
161 | Sumoylation | MASATLFKKEPPKPP CCCCCCCCCCCCCCC | 60.38 | - | |
161 | Sumoylation | MASATLFKKEPPKPP CCCCCCCCCCCCCCC | 60.38 | - | |
162 | Ubiquitination | ASATLFKKEPPKPPL CCCCCCCCCCCCCCC | 69.03 | 29967540 | |
166 | Ubiquitination | LFKKEPPKPPLNNFK CCCCCCCCCCCCCCC | 70.72 | 29967540 | |
173 | Ubiquitination | KPPLNNFKVGMKLEA CCCCCCCCCEEEEEE | 39.75 | 29967540 | |
177 | Sumoylation | NNFKVGMKLEAIDKK CCCCCEEEEEECCCC | 36.93 | - | |
177 | Sumoylation | NNFKVGMKLEAIDKK CCCCCEEEEEECCCC | 36.93 | - | |
177 | Ubiquitination | NNFKVGMKLEAIDKK CCCCCEEEEEECCCC | 36.93 | 29967540 | |
184 | Sumoylation | KLEAIDKKNPYLICP EEEECCCCCCEEECC | 60.45 | - | |
184 | Sumoylation | KLEAIDKKNPYLICP EEEECCCCCCEEECC | 60.45 | - | |
184 | Ubiquitination | KLEAIDKKNPYLICP EEEECCCCCCEEECC | 60.45 | 29967540 | |
248 | Ubiquitination | GTSVPIVKNIAKTES CCCCCEEEEEECCCC | 43.27 | 29967540 | |
252 | Sumoylation | PIVKNIAKTESSPSE CEEEEEECCCCCHHH | 49.37 | - | |
252 | Sumoylation | PIVKNIAKTESSPSE CEEEEEECCCCCHHH | 49.37 | - | |
253 | Phosphorylation | IVKNIAKTESSPSEA EEEEEECCCCCHHHH | 31.88 | 21712546 | |
255 | Phosphorylation | KNIAKTESSPSEASQ EEEECCCCCHHHHHH | 53.43 | 25159151 | |
256 | Phosphorylation | NIAKTESSPSEASQH EEECCCCCHHHHHHH | 26.64 | 23401153 | |
258 | Phosphorylation | AKTESSPSEASQHSM ECCCCCHHHHHHHCC | 47.98 | 23401153 | |
261 | Phosphorylation | ESSPSEASQHSMQSP CCCHHHHHHHCCCCC | 25.11 | 25159151 | |
264 | Phosphorylation | PSEASQHSMQSPQKT HHHHHHHCCCCCCCE | 15.75 | 23401153 | |
267 | Phosphorylation | ASQHSMQSPQKTTLI HHHHCCCCCCCEEEE | 22.21 | 25159151 | |
271 | Phosphorylation | SMQSPQKTTLILPTQ CCCCCCCEEEEEECH | 22.91 | 27174698 | |
272 | Phosphorylation | MQSPQKTTLILPTQQ CCCCCCEEEEEECHH | 20.88 | 27174698 | |
277 | Phosphorylation | KTTLILPTQQVRRSS CEEEEEECHHHHHHC | 28.34 | 27174698 | |
283 | Phosphorylation | PTQQVRRSSRIKPPG ECHHHHHHCCCCCCC | 17.26 | 29396449 | |
284 | Phosphorylation | TQQVRRSSRIKPPGP CHHHHHHCCCCCCCC | 35.89 | 29396449 | |
292 | Phosphorylation | RIKPPGPTAVPKRSS CCCCCCCCCCCCCCC | 46.32 | 29396449 | |
296 | Acetylation | PGPTAVPKRSSSVKN CCCCCCCCCCCCCCC | 59.31 | 7707299 | |
296 | Ubiquitination | PGPTAVPKRSSSVKN CCCCCCCCCCCCCCC | 59.31 | 24816145 | |
298 | Phosphorylation | PTAVPKRSSSVKNIT CCCCCCCCCCCCCCC | 32.84 | 26434776 | |
299 | Phosphorylation | TAVPKRSSSVKNITP CCCCCCCCCCCCCCC | 43.09 | 18669648 | |
300 | Phosphorylation | AVPKRSSSVKNITPR CCCCCCCCCCCCCCC | 38.05 | 23401153 | |
302 | Ubiquitination | PKRSSSVKNITPRKK CCCCCCCCCCCCCCC | 44.58 | 29967540 | |
305 | Phosphorylation | SSSVKNITPRKKGPN CCCCCCCCCCCCCCC | 26.83 | 23401153 | |
318 | Sumoylation | PNSGKKEKPLPVICS CCCCCCCCCCCEEEC | 61.81 | - | |
318 | Acetylation | PNSGKKEKPLPVICS CCCCCCCCCCCEEEC | 61.81 | 25953088 | |
318 | Sumoylation | PNSGKKEKPLPVICS CCCCCCCCCCCEEEC | 61.81 | - | |
326 | Phosphorylation | PLPVICSTSAASLKS CCCEEECCCCHHHHH | 20.27 | 19413330 | |
332 | Acetylation | STSAASLKSLTRDRG CCCCHHHHHHHCCCC | 40.71 | 25953088 | |
332 | Ubiquitination | STSAASLKSLTRDRG CCCCHHHHHHHCCCC | 40.71 | 32015554 | |
333 | Phosphorylation | TSAASLKSLTRDRGM CCCHHHHHHHCCCCC | 40.02 | 20068231 | |
335 | Phosphorylation | AASLKSLTRDRGMLY CHHHHHHHCCCCCCH | 37.30 | 20068231 | |
343 | Ubiquitination | RDRGMLYKDVASGPC CCCCCCHHHHCCCCC | 41.59 | 29967540 | |
374 | Ubiquitination | FGPHLDPKRIQQLPD CCCCCCHHHHHHCCC | 62.90 | 29967540 | |
407 | Acetylation | VDCALETKTVFGYLK HHHHHHCCEEEEEEC | 33.06 | 7987909 | |
482 | Acetylation | HSSAEHDKNQSAKED CCCHHHCCCCCHHHH | 59.81 | 18526221 | |
487 | Sumoylation | HDKNQSAKEDVTERQ HCCCCCHHHHHHHHH | 60.74 | - | |
487 | Sumoylation | HDKNQSAKEDVTERQ HCCCCCHHHHHHHHH | 60.74 | - | |
495 | Phosphorylation | EDVTERQSTKRSPQQ HHHHHHHHCCCCCCC | 41.96 | 23927012 | |
496 | Phosphorylation | DVTERQSTKRSPQQT HHHHHHHCCCCCCCC | 23.34 | 23927012 | |
499 | Phosphorylation | ERQSTKRSPQQTVPY HHHHCCCCCCCCCCE | 28.72 | 22167270 | |
503 | Phosphorylation | TKRSPQQTVPYVVPL CCCCCCCCCCEEEEC | 20.43 | 22167270 | |
506 | Phosphorylation | SPQQTVPYVVPLSPK CCCCCCCEEEECCCC | 15.11 | 30266825 | |
511 | Phosphorylation | VPYVVPLSPKLPKTK CCEEEECCCCCCCCH | 17.58 | 25159151 | |
517 | Phosphorylation | LSPKLPKTKEYASEG CCCCCCCCHHHHCCC | 27.46 | 26074081 | |
518 | Sumoylation | SPKLPKTKEYASEGE CCCCCCCHHHHCCCC | 55.65 | 28112733 | |
518 | Ubiquitination | SPKLPKTKEYASEGE CCCCCCCHHHHCCCC | 55.65 | 29967540 | |
520 | Phosphorylation | KLPKTKEYASEGEPL CCCCCHHHHCCCCCC | 19.58 | 26074081 | |
522 | Phosphorylation | PKTKEYASEGEPLFA CCCHHHHCCCCCCCC | 45.28 | 21815630 | |
536 | Sumoylation | AGGSAIPKEENLSED CCCCCCCCCCCCCCC | 72.11 | - | |
536 | Sumoylation | AGGSAIPKEENLSED CCCCCCCCCCCCCCC | 72.11 | 28112733 | |
536 | Ubiquitination | AGGSAIPKEENLSED CCCCCCCCCCCCCCC | 72.11 | 29967540 | |
544 | Phosphorylation | EENLSEDSKSSSLNS CCCCCCCCCCCCCCC | 30.31 | 20068231 | |
545 | Sumoylation | ENLSEDSKSSSLNSG CCCCCCCCCCCCCCC | 67.68 | - | |
545 | Sumoylation | ENLSEDSKSSSLNSG CCCCCCCCCCCCCCC | 67.68 | - | |
545 | Ubiquitination | ENLSEDSKSSSLNSG CCCCCCCCCCCCCCC | 67.68 | 32015554 | |
546 | Phosphorylation | NLSEDSKSSSLNSGN CCCCCCCCCCCCCCC | 29.16 | 25627689 | |
547 | Phosphorylation | LSEDSKSSSLNSGNY CCCCCCCCCCCCCCC | 42.45 | 25627689 | |
548 | Phosphorylation | SEDSKSSSLNSGNYL CCCCCCCCCCCCCCC | 38.37 | 25627689 | |
551 | Phosphorylation | SKSSSLNSGNYLNPA CCCCCCCCCCCCCHH | 33.44 | 28555341 | |
564 | Phosphorylation | PACRNPMYIHTSVSQ HHHCCCEEEEEECCC | 7.27 | 29978859 | |
567 | Phosphorylation | RNPMYIHTSVSQDFS CCCEEEEEECCCCCC | 22.67 | 29978859 | |
568 | O-linked_Glycosylation | NPMYIHTSVSQDFSR CCEEEEEECCCCCCC | 12.95 | 30059200 | |
568 | Phosphorylation | NPMYIHTSVSQDFSR CCEEEEEECCCCCCC | 12.95 | 28450419 | |
570 | O-linked_Glycosylation | MYIHTSVSQDFSRSV EEEEEECCCCCCCCC | 24.65 | 30059200 | |
570 | Phosphorylation | MYIHTSVSQDFSRSV EEEEEECCCCCCCCC | 24.65 | 17525332 | |
574 | Phosphorylation | TSVSQDFSRSVPGTT EECCCCCCCCCCCCC | 31.75 | 28450419 | |
576 | Phosphorylation | VSQDFSRSVPGTTSS CCCCCCCCCCCCCCC | 31.31 | 21712546 | |
580 | Phosphorylation | FSRSVPGTTSSPLVG CCCCCCCCCCCCCCC | 19.89 | 21712546 | |
581 | Phosphorylation | SRSVPGTTSSPLVGD CCCCCCCCCCCCCCC | 32.87 | 21712546 | |
582 | Phosphorylation | RSVPGTTSSPLVGDI CCCCCCCCCCCCCCC | 29.78 | 25159151 | |
583 | Phosphorylation | SVPGTTSSPLVGDIS CCCCCCCCCCCCCCC | 21.84 | 23401153 | |
590 | Phosphorylation | SPLVGDISPKSSPHE CCCCCCCCCCCCCCC | 30.89 | 29255136 | |
593 | Phosphorylation | VGDISPKSSPHEVKF CCCCCCCCCCCCCEE | 53.11 | 27362937 | |
594 | Phosphorylation | GDISPKSSPHEVKFQ CCCCCCCCCCCCEEE | 36.08 | 27362937 | |
599 | Sumoylation | KSSPHEVKFQMQRKS CCCCCCCEEEEECCC | 27.22 | - | |
599 | Acetylation | KSSPHEVKFQMQRKS CCCCCCCEEEEECCC | 27.22 | 26051181 | |
599 | Sumoylation | KSSPHEVKFQMQRKS CCCCCCCEEEEECCC | 27.22 | 28112733 | |
599 | Ubiquitination | KSSPHEVKFQMQRKS CCCCCCCEEEEECCC | 27.22 | 32015554 | |
605 | Sumoylation | VKFQMQRKSEAPSYI CEEEEECCCCCCCEE | 35.44 | - | |
605 | Sumoylation | VKFQMQRKSEAPSYI CEEEEECCCCCCCEE | 35.44 | 28112733 | |
605 | Ubiquitination | VKFQMQRKSEAPSYI CEEEEECCCCCCCEE | 35.44 | 29967540 | |
606 | Phosphorylation | KFQMQRKSEAPSYIA EEEEECCCCCCCEEE | 40.97 | 25159151 | |
610 | Phosphorylation | QRKSEAPSYIAVPDP ECCCCCCCEEECCCH | 35.90 | 29449344 | |
611 | Phosphorylation | RKSEAPSYIAVPDPS CCCCCCCEEECCCHH | 7.58 | 27642862 | |
621 | Sumoylation | VPDPSVLKQGFSKDP CCCHHHHHCCCCCCC | 46.34 | - | |
621 | Ubiquitination | VPDPSVLKQGFSKDP CCCHHHHHCCCCCCC | 46.34 | 29967540 | |
663 | Ubiquitination | RQHEIDGKALFLLKS HHCCCCCEEEEEECH | 37.86 | 29967540 | |
670 | Phosphorylation | KALFLLKSDVMMKYM EEEEEECHHHHHHHC | 35.09 | 21406692 | |
680 | Sumoylation | MMKYMGLKLGPALKL HHHHCCCCHHHHHHH | 45.74 | - | |
680 | Sumoylation | MMKYMGLKLGPALKL HHHHCCCCHHHHHHH | 45.74 | - | |
693 | Acetylation | KLCYYIEKLKEGKYS HHHHHHHHHHCCCCC | 56.13 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
267 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
267 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
305 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
305 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
511 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
511 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
590 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
590 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SCML2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SCML2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BAG1_HUMAN | BAG1 | physical | 26344197 | |
UBP7_HUMAN | USP7 | physical | 25605328 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499; TYR-506; SER-511AND SER-590, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-253; SER-255; SER-267;SER-499; THR-503; TYR-506; SER-511; SER-582; SER-583 AND SER-590, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256; SER-258; SER-267;SER-299; SER-300; THR-305; SER-499; THR-503; SER-511; SER-576;SER-583; SER-590 AND SER-594, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570, AND MASSSPECTROMETRY. |